Metabolomic changes in autopsy-confirmed Alzheimer's disease

Metabolomic changes in autopsy-confirmed Alzheimer's disease

10.1016/j.jalz.2010.06.001

Saved in:

Bibliographic Details
Main Authors:	Kaddurah-Daouk, R., Rozen, S., Matson, W., Han, X., Hulette, C.M., Burke, J.R., Doraiswamy, P.M., Welsh-Bohmer, K.A.
Other Authors:	DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE
Format:	Article
Published:	2014
Subjects:	Alzheimer's Biomarkers Diagnosis Metabolomics Purine Staging Tryptophan Tyrosine
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/110170
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

Alterations in tryptophan and purine metabolism in cocaine addiction: A metabolomic study
by: Patkar, A.A., et al.
Published: (2014)

Alterations in metabolic pathways and networks in Alzheimer's disease
by: Kaddurah-Daouk, R., et al.
Published: (2014)

FORMULATION DEVELOPMENT AND BRAIN DELIVERY OF ANTIOXIDANT AND ANTI-INFLAMMATORY DRUGS AS POTENTIAL TREATMENT OF ALZHEIMER'S DISEASE: PHARMACOKINETICS, PHARMACODYNAMICS, AND METABOLOMICS
by: ZHANG LI
Published: (2021)

Metabolomics in early Alzheimer's disease: Identification of altered plasma sphingolipidome using shotgun lipidomics
by: Han, X., et al.
Published: (2014)

Biomarker profiling of ageing and neurodegenerative disease
Published: (2010)

ASSESSING POTENTIAL INFLAMMATORY BIOMARKERS AND ANTI-NEUROINFLAMMATORY THERAPIES FOR ALZHEIMER'S DISEASE
by: ZHU YANAN
Published: (2018)

Serum metabolomics investigation of humanized mouse model of dengue virus infection
by: Cui, L, et al.
Published: (2020)

Altered gut microbial metabolites in amnestic mild cognitive impairment and alzheimer's disease : signals in host-microbe interplay
by: Wu, Li, et al.
Published: (2021)

Peripheral biomarkers for early detection of Alzheimer's and Parkinson's diseases
by: Htike, Thein Than, et al.
Published: (2020)

AN ISOFORM-SPECIFIC ROLE OF FYNT IN ALZHEIMER'S DISEASE AND ITS RELEVANCE IN NEUROINFLAMMATION
by: LEE CHING LI
Published: (2016)

MULTI-PLATFORM METABOLOMICS APPROACH COUPLED WITH GLYCOMICS IN IDENTIFYING MARKERS FOR ASTHMA IN SERUM AND SPUTUM SAMPLES
by: NG BAO HUI
Published: (2022)

Upregulated blood miR-150-5p in alzheimer's disease dementia is associated with cognition, cerebrospinal fluid amyloid-β, and cerebral atrophy
by: Chia, Sook Yoong, et al.
Published: (2023)

Opioid use affects antioxidant activity and purine metabolism: Preliminary results
by: Mannelli, P., et al.
Published: (2014)

Identification of Key Genes in Purine Metabolism as Prognostic Biomarker for Hepatocellular Carcinoma
by: Su, Wen-Jing, et al.
Published: (2022)

Clinical and biomarker trajectories in sporadic Alzheimer's disease: A longitudinal study
by: Wang, H.-F., et al.
Published: (2021)

ENVIRONMENTAL METABOLOMICS OF FRESHWATER PHYTOPLANKTONS
by: ZHANG WENLIN
Published: (2016)

The Prognostic Utility of CSF Neurogranin in Predicting Future Cognitive Decline in the Alzheimer’s Disease Continuum: A Systematic Review and Meta-Analysis
by: YOONG SI QI
Published: (2021)

Metabolomics and modelling approaches for systems metabolic engineering
by: Khanijou, Jasmeet Kaur, et al.
Published: (2023)

Network dysfunction in Alzheimer's disease and frontotemporal dementia: Implications for psychiatry
by: Zhou, J., et al.
Published: (2016)

METABOLOMICS-BASED INVESTIGATION OF THE TOXICITY OF EMERGING ORGANIC CONTAMINANTS IN ZEBRAFISH EMBRYOS
by: PRITI MISHRA
Published: (2019)

Cerebrospinal fluid and serum antimicroglial antibodies: Prospects for early diagnosis of Alzheimer's disease
by: McRae, A., et al.
Published: (2012)

Use of Metabolomics in Biomedical and Environmental Studies
by: HUANG SHAOMIN
Published: (2015)

PLATFORM DEVELOPMENT FOR THE BLOOD-BASED DETECTION OF ALZHEIMER’S DISEASE
by: LIM ZHI JUN CARINE
Published: (2021)

Metabonomic profiling of TASTPM transgenic Alzheimer's disease mouse model
by: Hu, Z.-P., et al.
Published: (2014)

Orthogonal Partial Least Squares - Discriminant Analysis in Metabolomic for Disease Characterization
by: CHEW AI PING
Published: (2013)

Biomarkers of mild cognitive impairment and Alzheimer's disease
by: Tang, B.L., et al.
Published: (2011)

Chronic treatment with baicalein alleviates behavioural disorders and improves cerebral blood flow via reverting metabolic abnormalities in a J20 transgenic mouse model of Alzheimer's disease
by: Zhang, L, et al.
Published: (2023)

NOVEL OXIDATIVE STRESS-ASSOCIATED BIOMARKERS OF ALZHEIMER’S DISEASE AND VASCULAR COGNITIVE IMPAIRMENT
by: WU LIUYUN
Published: (2024)

Fused heterocyclic systems with an s-triazine ring. 34. Development of a Practical Approach for the Synthesis of 5-Aza-isoguanines
by: Junaid, A., et al.
Published: (2021)

Living and loving with alzheimer's
by: Marasigan, Marissa C.
Published: (2017)

Pretreatment metabotype as a predictor of response to sertraline or placebo in depressed outpatients: A proof of concept
by: Kaddurah-Daouk, R., et al.
Published: (2014)

Serum metabolome changes in adult patients with severe dengue in the critical and recovery phases of dengue infection
by: Cui L., et al.
Published: (2019)

Tienma and Alzheimer's disease
by: Huang, Junjie
Published: (2013)

Deciphering the correlations between aging and constipation by metabolomics and network pharmacology
by: Liu, Xiaojie, et al.
Published: (2021)

Characterization of the human tear metabolome by LC-MS/MS
by: Chen, L., et al.
Published: (2014)

Effect of dietary purines on the pharmacokinetics of orally administered ribavirin
by: Li, L., et al.
Published: (2011)

Dose-response metabolomics and pathway sensitivity to map molecular cartography of bisphenol A exposure
by: Zhao, Haoduo, et al.
Published: (2022)

THE EFFECTIVENESS OF ONLINE MEMORY TRAINING INTERVENTION IN IMPROVING MEMORY FOR PEOPLE DIAGNOSED WITH EARLY-STAGE DEMENTIA: A SYSTEMATIC REVIEW AND META-ANALYSIS
by: SERENE PANG SHI HUI
Published: (2019)

Stability analysis of the ODE model representation of Amyloidogenic processing in Alzheimer's disease in the presence of SORLA
by: Alcantara, Jan Harold Mercado
Published: (2015)

Truncated Tau caused by intron retention is enriched in Alzheimer’s disease cortex and exhibits altered biochemical properties
by: Ngian, ZK, et al.
Published: (2023)